Showing results (401-410 of 753) with videos related to
Sort By:
Pageof 76
International Journal of Radiation Oncology, Biology, Physics|May 10, 2011
Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51Thomas B Daniels, Paul D Brown, Sara J Felten, et al.Journal of Neuro-Oncology|October 21, 2023
Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastomaRoy Strowd, Benjamin Ellingson, Catalina Raymond, et al.Journal of Neuro-Oncology|January 20, 2011
Lonafarnib (SCH66336) improves the activity of temozolomide and radiation for orthotopic malignant gliomasDeviney Chaponis, Jessica W Barnes, Jamie L Dellagatta, et al.Oncotarget|September 20, 2014
Combined VEGF and CXCR4 antagonism targets the GBM stem cell population and synergistically improves survival in an intracranial mouse model of glioblastomaAmy Barone, Rajarshi Sengupta, Nicole M Warrington, et al.Neuro-Oncology|May 29, 2014
Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trialsMarc Chamberlain, Riccardo Soffietti, Jeffrey Raizer, et al.Cancer Research|September 24, 2009
MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenesYunqing Li, Fadila Guessous, Ying Zhang, et al.Neuroradiology|August 11, 2022
MRI features predict tumor grade in isocitrate dehydrogenase (IDH)-mutant astrocytoma and oligodendrogliomaDavid A Joyner, John Garrett, Prem P Batchala, et al.Cancer Research|August 17, 2019
Tie2-FGFR1 Interaction Induces Adaptive PI3K Inhibitor Resistance by Upregulating Aurora A/PLK1/CDK1 Signaling in GlioblastomaXiaolong Li, Emmanuel Martinez-Ledesma, Chen Zhang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Evaluation of the Safety and Benefit of Phase I Oncology Trials for Patients With Primary CNS TumorsMrinal M Gounder, Lakshmi Nayak, Solmaz Sahebjam, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08Patrick Y Wen, W K Alfred Yung, Kathleen R Lamborn, et al.Pageof 76